Dr. Christopher Newth, MD
Claim this profileChildren's Hospital of Los Angeles
Studies Pulmonary Injury
Studies Ventilation Therapy Complications
2 reported clinical trials
2 drugs studied
Affiliated Hospitals
Clinical Trials Christopher Newth, MD is currently running
Hydrocortisone
for Pediatric Septic Shock
SHIPSS is a multi-institutional, prospective, controlled, randomized, double-blinded interventional trial that will examine the potential benefits and risks of adjunctive hydrocortisone prescribed for children with fluid and vasoactive-inotropic refractory septic shock. It is hypothesized that adjunctive hydrocortisone will significantly reduce the incidence of new and progressive organ dysfunction (primary outcome) and proportion of children with poor outcomes, defined as death or severely impaired health-related quality of life (HRQL) (secondary outcome), as assessed at 28 days following study enrollment (randomization).
Recruiting1 award Phase 3
Ventilator Protocol
for Pediatric Acute Respiratory Distress Syndrome
Previous clinical trials in adults with acute respiratory distress syndrome (ARDS) have demonstrated that ventilator management choices can improve Intensive Care Unit (ICU) mortality and shorten time on mechanical ventilation. This study seeks to scale an established Clinical Decision Support (CDS) tool to facilitate dissemination and implementation of evidence-based research in mechanical ventilation of infants and children with pediatric ARDS (PARDS). This will be accomplished by using CDS tools developed and deployed in Children's Hospital Los Angeles (CHLA) which are based on the best available pediatric evidence, and are currently being used in an NHLBI funded single center randomized controlled trial (NCT03266016, PI: Khemani). Without CDS, there is significant variability in ventilator management of PARDS patients both between and within Pediatric ICUs (PICUs), but clinicians are willing to accept CDS recommendations. The CDS tool will be deployed in multiple PICUs, targeting enrollment of up to 180 children with PARDS. Study hypotheses: 1. The CDS tool in will be implementable in nearly all participating sites 2. There will be \> 80% compliance with CDS recommendations and 3. The investigators can implement automatic data capture and entry in many of the ICUs Once feasibility of this CDS tool is demonstrated, a multi-center validation study will be designed, which seeks to determine whether the CDS can result in a significant reduction in length of mechanical ventilation (LMV).
Recruiting1 award N/A3 criteria
More about Christopher Newth, MD
Clinical Trial Related6 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Christopher Newth, MD has experience with
- Clinical Decision Support Tool
- Hydrocortisone
Breakdown of trials Christopher Newth, MD has run
Ventilation Therapy Complications
Ventilator-Induced Lung Injury
Acute respiratory distress syndrome
Septic Shock
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Christopher Newth, MD specialize in?
Christopher Newth, MD focuses on Pulmonary Injury and Ventilation Therapy Complications. In particular, much of their work with Pulmonary Injury has involved treating patients, or patients who are undergoing treatment.
Is Christopher Newth, MD currently recruiting for clinical trials?
Yes, Christopher Newth, MD is currently recruiting for 2 clinical trials in Los Angeles California. If you're interested in participating, you should apply.
Are there any treatments that Christopher Newth, MD has studied deeply?
Yes, Christopher Newth, MD has studied treatments such as Clinical Decision Support Tool, Hydrocortisone.
What is the best way to schedule an appointment with Christopher Newth, MD?
Apply for one of the trials that Christopher Newth, MD is conducting.
What is the office address of Christopher Newth, MD?
The office of Christopher Newth, MD is located at: Children's Hospital of Los Angeles, Los Angeles, California 90027 United States. This is the address for their practice at the Children's Hospital of Los Angeles.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.